SCHOFIELD, Wis., Feb. 16, 2010 (GLOBE NEWSWIRE) -- PuraMed BioScience (OTCBB:PMBS), a pharmaceutical company engaged in the development and marketing of a line of revolutionary, new, non-prescription medicines that treat migraine headaches, insomnia and tension-type headaches under the brand name LipiGesic™, announced today that it will host a shareholder conference call on Thursday, Feb. 18, 2010, at 4:10 p.m. EST (3:10 p.m. CST) to discuss quarterly earnings and to provide a corporate update. The call will begin with a 15-minute presentation followed by a Q&A session.
"We look forward to having the opportunity to communicate with PuraMed shareholders and interested parties about the quarterly earnings we have just released," said PuraMed BioScience CEO Russell Mitchell. "This 10Q reflects our first revenue, although only the first week of sales was covered in this quarter. In this call, we plan to discuss how this revenue is just the start of plans for continued growth."
Participation in the call is open to all interested parties. Participants may use the following phone numbers to take part in the call. Within the U.S. and Canada dial (Toll Free): 877-872-0592. International participants can dial: 706-679-9989. Participants will be asked to provide the following conference ID number: 55913364.
A replay will be made available by dialing 800-642-1687 or 706-645-9291 and entering the conference ID number 55913364. This replay will be made available until April 18, 2010.
About the Company:
PuraMed BioScience, Inc. engages in the research, development and marketing of non-prescription medicinal and healthcare products. In addition to its leading product LipiGesic™ M, which provides acute relief from migraine headaches, the Company also has plans to launch LipiGesic™ PM that provides a remedy for insomnia and other sleep disorders as well as LipiGesic™ H for common tension headaches. For more information on PuraMed, visit the Company website at www.PuraMedBioScience.com, join the Company's group page on Facebook by searching "PuraMed BioScience" and follow the Company on Twitter at www.twitter.com/puramed.
Forward Looking Statements:
This news release contains forward-looking statements regarding PuraMed BioScience and its future business plans, which statements involve known and unknown risks and uncertainties. Such risks and uncertainties may cause actual results and future achievements of PuraMed BioScience to be materially different than those implied by these forward-looking statements. PuraMed BioScience has and undertakes no obligation to provide public updates and revisions to these forward-looking statements to reflect any changes in its expectations of future events.